Authors
Latest:
Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulasOlder generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
Latest:
Netarsudil provides IOP lowering in goniotomy treated eyesThe unique MOA may deliver a synergistic effect when prescribed post-surgically.
Latest:
Shifting paradigm in GA management means focusing attention on imagingOphthalmologists can use OCT to find the early signs of disease
Latest:
Advancement in TED treatment is a bright spotFDA approval of teprotumumab as therapeutic offers hope for patients.
Latest:
Protecting cataract patients and their surgeons' practicesMaximizing refractive surgery is key to ensuring prosperous future
Latest:
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linkingJohn D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Latest:
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconusEhsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.
Latest:
AAO 2024: Enhancing the paradigm of 'see one, do one, teach one' with technologyBonnie An Henderson, MD, highlights the importance of diverse learning methods and continuous education for clinicians in the Kelman Lecture.
Latest:
AAO 2024: Suprachoroidal drug delivery in the real worldGlenn C. Yiu, MD, PhD, from the University of California David, shared insights from his presentation on suprachoroidal drug delivery in the real world at this year's AAO meeting held in Chicago, Illinois.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Focusing on postinjection endophthalmitisSystemic immunosuppression may prevent devastating complication in patients.
Latest:
Seize underutilized opportunity to treat glaucoma during vitrectomyOphthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Latest:
Benefits of topography-guided treatments for irregular corneasProcedure can improve best-corrected visual acuity, enhancing quality of life for patients.
Latest:
Inherited retinal diseases meet their therapeutic matchThe retina is a key proving ground for long-held theories of genetics.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed to eliminate errors results in optimization of training of novice surgeons.
Latest:
Considerations for the Future of Biosimilars in the Treatment of Retinal DisordersCarl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Latest:
Weighing treatments for chronic postop cystoid macular edemaPrompt and adequate action is a key to facilitating the best recovery in patients.
Latest:
FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasisOcuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLsKamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
Latest:
The eyes offer conjunctival clue to COVID-19A patient's vision loss leads to another diagnosis
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
CIME 2024: Neda Shamie, MD, recaps a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussionThe 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.
Latest:
From waste to wonder: Transformational advances in scleral allograft technologyUnlocking the potential of donor scleral tissue: Innovations and future applications.
